Regeneron’s Commitment to Sustainability Recognized
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has recently announced its impressive sixth consecutive inclusion in the Dow Jones Sustainability World Index (DJSI World) and its fifth consecutive listing in the Dow Jones Sustainability North America Index (DJSI North America). This accolade showcases the company’s unwavering commitment to adopting responsible business practices that not only enhance its resilience but also contribute positively to the world around us.
Understanding the Dow Jones Sustainability World Index
The DJSI World Index serves as a prominent benchmark for corporate sustainability, identifying the top 10 percent of the most sustainable companies across various industries globally. Among these distinguished organizations, Regeneron is one of only six biotechnology firms included, demonstrating its leadership in responsible corporate conduct. Impressively, Regeneron's score positions it within the top 1 percent of all rated biotechnology companies around the globe, a testament to its significant progress in areas such as Societal Healthcare, Human Capital Management, and overall Corporate Governance.
Leadership Insights from Regeneron’s Executives
“Our corporate responsibility framework is deeply integrated into our mission and values,” expressed Leonard S. Schleifer, M.D., Ph.D., co-founder and CEO of Regeneron. “By focusing on issues most pertinent to our stakeholders, including patients and investors, we embody our motto to ‘Do Well by Doing Good.’ This involves broadening access to our medications while simultaneously upholding the highest ethical standards, playing a vital role in protecting and restoring the environment for communities across the globe.”
Strategic Focus Areas for Corporate Responsibility
At the heart of Regeneron’s strategy are three pivotal areas: enhancing the lives of individuals battling serious diseases, cultivating a culture anchored in integrity and excellence, and promoting sustainable communities. This holistic approach not only captures the essence of Regeneron's operations but also aligns with its long-term business objectives.
Annual Responsibility Report Insights
The company annually publishes a Responsibility Report that transparently outlines its progress toward reaching its ambitious 2025 global goals. This report includes updates on numerous initiatives, such as the development of approximately 40 investigational medicines, setting responsible artificial intelligence practices, addressing global pay equity, and improving access to critical treatments, including its Ebola therapy in under-resourced regions.
Noteworthy Performance Metrics
Regeneron's commitment to excellence is reflected in its strong performance across various environmental, social, and governance (ESG) assessments. The company boasts high rankings in the Sustainalytics Risk Rating, ISS ESG Corporate Rating, and the FTSE4Good Index Series. Such acknowledgments reinforce Regeneron’s proactive measures to both foresee and address potential ESG risks while seizing available opportunities.
Looking Ahead: Regeneron’s Ongoing Commitment
As Regeneron pushes forward, its focus remains on responsible innovation and maintaining transparent practices that elevate societal standards. Christina Chan, Senior Vice President of Corporate Affairs at Regeneron, underlined the company’s drive, stating, “Our ongoing high rankings in renowned ESG indices symbolize meaningful advancements toward our 2025 objectives while showcasing our dedication to utilizing science to enhance lives, communities, and our planet.”
Conclusion: The Importance of Corporate Citizenship
Regeneron recognizes that being a responsible corporate citizen is fundamental to fulfilling its mission of improving lives. The biopharmaceutical company actively integrates community engagement into its culture, encouraging employees to partake in initiatives that foster excellence across various sectors. Notably, Regeneron stands out as a member of the esteemed Civic 50, listing it among the most community-oriented companies in the United States.
Frequently Asked Questions
What is the Dow Jones Sustainability World Index?
The Dow Jones Sustainability World Index is a benchmark for corporate sustainability, highlighting the top 10% of sustainable companies in various industries worldwide.
How often does Regeneron publish its Responsibility Report?
Regeneron releases its Responsibility Report annually, providing updates on its sustainability goals and performance metrics.
Why is Regeneron included in the Civic 50?
Regeneron was included in the Civic 50 for its commitment to community engagement and significant philanthropic contributions, particularly in science education.
What are the key focus areas of Regeneron’s corporate responsibility strategy?
The main focus areas include improving the lives of individuals with serious diseases, fostering a culture of integrity, and building sustainable communities.
What recognition has Regeneron received for its ESG efforts?
Regeneron has achieved high ratings in the Sustainalytics Risk Rating, ISS ESG Corporate Rating, and is included in the FTSE4Good Index Series, reflecting its robust ESG initiatives.
